Back to CVE records
Medium 4.4HealthcarePublished Aug 10, 2018

CVE-2018-10626Medtronic MyCareLink 24950 Patient Monitor Insufficient Verification of Data Authenticity

Updated under an hour ago ()

Does this affect you?

It affects Medtronic 24950 MyCareLink Monitor and 3 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.36%, higher than 28% of scored CVEs.

Medtronic MyCareLink Patient Monitor’s update service does not sufficiently verify the authenticity of the data uploaded. An attacker who obtains per-product credentials from the monitor and paired implantable cardiac device information can potentially upload invalid data to the Medtronic CareLink network.

CVSS
4.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:A/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:N
Weakness (CWE)
CWE-345
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.36% (percentile 28)
Assigned by
icscert
NVD analysis
Modified
Record last updated
May 19, 2026
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Medtronic 24950 MyCareLink Monitor
medtronic:24950_mycarelink_monitor (from the name)
all versions
CNA record
Medtronic 24952 MyCareLink Monitor
medtronic:24952_mycarelink_monitor (from the name)
all versions
CNA record
medtronic mycarelink_24952_patient_monitor_firmware
medtronic:mycarelink_24952_patient_monitor_firmware
all versions
NVD
medtronic mycarelink_24950_patient_monitor_firmware
medtronic:mycarelink_24950_patient_monitor_firmware
all versions
NVD

References

  • vdb-entry, third-party-advisory
  • third-party-advisory, us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.